Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma. Mazzoni C, Argnani L, Casadei B, Broccoli A, et al. Eur J Haematol 2024 Sep 18. doi: 10.1111/ejh.14306.

Read + Share

Amedeo Smart

Independent Medical Education

Mazzoni C, Argnani L, Casadei B, Broccoli A, et al. Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma. Eur J Haematol 2024 Sep 18. doi: 10.1111/ejh.14306.
PMID: 39295142